Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability

New generation antidepressant therapies, including serotonin-norepinephrine reuptake inhibitor (SNRIs), were introduced in the late 1980s; however, few comprehensive studies have compared the benefits and risks of various contemporary treatments for major depressive disorder (MDD) in young patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Y., Bai, S.J., Lan, X.H., Qin, B., Huang, T., Xie, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2016
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897997/
https://www.ncbi.nlm.nih.gov/pubmed/27240293
http://dx.doi.org/10.1590/1414-431X20164806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897997/
https://www.ncbi.nlm.nih.gov/pubmed/27240293
http://dx.doi.org/10.1590/1414-431X20164806

Ejemplares similares